Skip to main content
Premium Trial:

Request an Annual Quote

Siemens, LabCorp Sign Diagnostic Co-Development Agreement

NEW YORK (GenomeWeb News) - Siemens Healthcare and Laboratory Corporation of America have agreed to "discuss future possibilities" to co-develop clinical diagnostic tests, the companies said today.
 
The non-exclusive agreement encompasses the areas of metabolic syndrome, oncology, diabetes, and companion diagnostics that are "designed to identify the suitability between patients and a particular drug therapy," the partners said.
 
"This agreement establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone," said Dave Hickey, senior vice president of strategic planning and business development at Siemens Healthcare Diagnostics, in a statement.
 
Myla Lai-Goldman, executive vice president, chief scientific officer, and medical director for LabCorp, said that the firm is particularly interested in the impact of the collaboration on the reference lab’s companion diagnostics efforts.
 
"Alliances, such as this between developers and providers of new tests, are critical in translating emerging biomarkers from research into clinical practice," she said.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.